5,813 reports of this reaction
3.1% of all MACITENTAN reports
#5 most reported adverse reaction
NAUSEA is the #5 most commonly reported adverse reaction for MACITENTAN, manufactured by Actelion Pharmaceuticals US, Inc.. There are 5,813 FDA adverse event reports linking MACITENTAN to NAUSEA. This represents approximately 3.1% of all 188,657 adverse event reports for this drug.
Patients taking MACITENTAN who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among MACITENTAN users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for MACITENTAN:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 5,813 FDA reports for MACITENTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.1% of all adverse event reports for MACITENTAN, making it a notable side effect.
If you experience nausea while taking MACITENTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.